M&A Update – April 25

– SPPI to be acquired by ASRT for 0.1783x shares + CVR, 65.4% premium, $248 million
– HLGN rejected $0.40 unsolicited proposal from Continuum Renewables
– FOCS / CD&R / Stone Point Capital filed PREM14a, cleared HSR Apr 12, closing Q3
– JNCE / Concentra Biosciences launched tender offer, expires May 3
– BLU / GSK set June 16 vote date
– SGEN / PFE filed DEFM14a, vote May 30, filed UK CMA Apr 21, closing late 2023 or early 2024
– APE / AMC hearing, joint desire for settlement hearing in late June
– CORE vote